Product Details | |
Generic Name | Sotorasib |
Strength | 120mg |
Medicine Form | Tablet |
Manufactured By | Everest Pharma |
Quantity | 56 Tablets |
Packaging Type | Bottle |
Sotoxen (Sotorasib 120 mg Tablets) is a prescription medication used for the treatment of specific types of non-small cell lung cancer (NSCLC). Sotorasib is a KRAS G12C inhibitor that works by targeting the KRAS G12C mutation, which is present in a subset of NSCLC patients, leading to the inhibition of cancer cell growth and proliferation.
Indications:
Sotoxen is indicated for the treatment of:
- Adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) who have received at least one prior systemic therapy.
How to Use:
- Take Sotoxen exactly as prescribed by your healthcare provider.
- Swallow the tablet whole with a full glass of water.
- Do not crush, chew, or break the tablet.
- It can be taken with or without food.
- Follow your doctor's instructions regarding dosage and duration of treatment.
Side Effects:
Common side effects of Sotoxen may include:
- Diarrhea
- Nausea
- Fatigue
- Liver enzyme elevation
- Cough
- Musculoskeletal pain
Precautions:
- Inform your healthcare provider about any existing medical conditions and medications you are taking.
- Regular monitoring of liver function tests may be required during treatment.
- Use effective contraception to avoid pregnancy while taking Sotoxen, as it may harm an unborn baby.
- Sotoxen is not recommended for use in breastfeeding women.
Storage:
- Store Sotoxen tablets at room temperature between 20°C to 25°C (68°F to 77°F).
- Keep the tablets in their original container, tightly closed.
- Keep out of reach of children.
Disclaimer:
This product description is provided for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional before starting any new medication.